Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.02.007Source: DataRank Database

SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR is a research paper published in Journal of Cystic Fibrosis (2021). On theSindex it has a DataRank of 0.416. It has been cited 15 times.

N/A

0.416DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.56)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.416

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (10)

Rhonda G. Pace ORCID,Hong Dang ORCID,Melis A. Aksit ORCID,Briana Vecchio-Pagán,Anh-Thu N. Lam

Live enrichment

PubMed:33674211 PMC:PMC8410892 OpenAlex:https://openalex.org/W3134023024

National Institutes of Health

Grant: CUTTIN17G0

National Institutes of Health

Grant: CUTTIN18XX0

National Institutes of Health

Grant: R01DK044003

University of Alabama

Cystic Fibrosis Foundation

FWCI

1.56

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8410892

publisherhttps://api.elsevier.com/content/article/PII:S1569199321000424?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199321000424?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcf.2021.02.007

Fields of Study

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchAsthma and respiratory diseasesAminophenolsAntiportersCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorFemaleGenotypeHumansMalePolymorphism, Single NucleotideProspective StudiesQuinolonesRespiratory Function TestsSeverity of Illness IndexSulfate TransportersYoung Adult

MeSH Terms

Sulfate TransportersAminophenolsCystic FibrosisFemaleGenotypeHumansMaleProspective StudiesRespiratory Function TestsSeverity of Illness IndexQuinolonesAntiportersCystic Fibrosis Transmembrane Conductance RegulatorPolymorphism, Single NucleotideYoung Adult

Keywords

IvacaftorCystic fibrosisMedicineCystic fibrosis transmembrane conductance regulatorInternal medicineLung functionLungOncologyModifier GenesG551dIvacaftor EfficacySlc26a9 Rs7512462

Sustainable Development Goals

SDG 0: Good health and well-being

SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR

FAIR Checklist

DataRank Breakdown

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)